In the last trading session, 14.26 million ProPhase Labs Inc (NASDAQ:PRPH) shares changed hands as the company’s beta touched -0.41. With the company’s per share price at $0.53 changed hands at -$0.06 or -9.49% during last session, the market valuation stood at $15.95M. PRPH’s last price was a discount, traded about -1311.32% off its 52-week high of $7.48. The share price had its 52-week low at $0.22, which suggests the last value was 58.49% up since then.
Analysts gave the ProPhase Labs Inc (PRPH) stock a consensus recommendation rating of Hold, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended PRPH as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight. ProPhase Labs Inc’s EPS for the current quarter is expected to be -0.24.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
Instantly PRPH was in red as seen at the end of in last trading. With action 57.06%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -29.47%, with the 5-day performance at 57.06% in the green. However, in the 30-day time frame, ProPhase Labs Inc (NASDAQ:PRPH) is 4.48% up.
The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 96.21% from its current market value. According to analyst projections, PRPH’s forecast low is 14 with 14 as the target high. To hit the forecast high, the stock’s price needs a -2541.51% plunge from its current level, while the stock would need to soar -2541.51% for it to hit the projected low.
ProPhase Labs Inc (PRPH) estimates and forecasts
Year-over-year growth is forecast to reach -71.22% down from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 3.77M. 1 analysts are of the opinion that ProPhase Labs Inc’s revenue for the current quarter will be 2.45M. The company’s revenue for the corresponding quarters a year ago was 4.35M and 3.63M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -13.35%. The estimates for the next quarter sales put growth at -32.58%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -47.90%. The 2025 estimates are for ProPhase Labs Inc earnings to decrease by -29.59%.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
RENAISSANCE TECHNOLOGIES LLC holds the second largest percentage of outstanding shares, with 1.222% or 0.22 million shares worth $0.92 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Perritt Microcap Opportunities Fund. With 454.64 shares estimated at $0.24 million under it, the former controlled 1.90% of total outstanding shares. On the other hand, Perritt Microcap Opportunities Fund held about 0.80% of the shares, roughly 190.0 shares worth around $0.1 million.
